Fmoc-N-Me-Ala-OH
Fmoc-N-Me-Ala-OH, an N-Fmoc-N-methyl amino acid, is available for the peptide-coupling reaction. Fmoc-N-Me-Ala-OH is a drug intermediate that can be used to synthesize ML-IAP Lys-covalent inhibitor[1][2].
Product Specifications
CAS Number
[84000-07-7]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Amino Acid Derivatives; Drug Intermediate
Type
Reference compound
Related Pathways
Others
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Fmoc-N-Me-Ala-OH.html
Concentration
10mM
Purity
99.92
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@H](N(C(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)C)C(O)=O
Molecular Formula
C19H19NO4
Molecular Weight
325.36
Precautions
H302, H315, H319, H335
References & Citations
[1]Harris KS, et al. Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning. J Biol Chem. 2009 Apr 3;284 (14) :9361-71.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0888308 1.0 µg DNA
GPM6B sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
127013-APC 100 µL
Fucosyltransferase 1 (FUT1, 2-alpha-L-fucosyltransferase 1, Alpha (1,2) FT 1, Blood Group H alpha 2-fucosyltransferase, Galactoside 2-alpha-L-fucosyltransferase 1, GDP-L-fucose:beta-D-galactoside, H, HH, HSC) (APC)
Sign In for Pricing
View Details 